Puget Sound Business Journal (Seattle) -- Cell Therapeutics Inc. said it’s adopted a shareholder rights plan that it says “is designed to deter coercive takeover tactics.” The new “rights plan” for the Seattle biotech will “prevent an acquirer from gaining control of CTI without offering a fair price to all of CTI’s shareholders,” officials said.
